by TractManager | Oct 21, 2022 | Health Technology Assessment
Focus of the Report: The focus of this Health Technology Assessment (HTA) is the evaluation of the effectiveness and safety of proton beam therapy (PBT) compared with conventional (photon-based) external beam radiation therapies for the treatment of esophageal...
by TractManager | Oct 18, 2022 | Precision Medicine Insights
This report reviews clinical study abstracts and clinical practice guidelines addressing comprehensive molecular profiling (CMP) of circulating solid tumor DNA as a broad molecular profiling tool to aid in decision making regarding biomarker-matched treatment...
by TractManager | Oct 18, 2022 | Precision Medicine Insights
This report reviews clinical study abstracts and clinical practice guidelines addressing comprehensive molecular profiling (CMP) of circulating solid tumor DNA as a broad molecular profiling tool to aid in monitoring for indicators of treatment response/failure or...
by TractManager | Oct 14, 2022 | Health Technology Assessment
Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the safety and effectiveness of proton beam therapy (PBT) for the treatment of breast cancer with no distant metastasis. This HTA also compares the safety and effectiveness of PBT...
by TractManager | Oct 14, 2022 | Emerging Technology Report
Revita DMR is an investigational endoscopic hydrothermal ablation device for duodenal mucosal resurfacing proposed for treatment of type 2 diabetes that is poorly controlled with oral medications and/or insulin.If you have a Hayes login, click here to view the full...
Recent Comments